Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for viral sore throat pain relief
ACTRN12618000847213Phase 2Not yet recruiting
- Sponsor
- Asma Al Shidhani
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of dexamethasone in pharyngitis and upper respiratory tract infection (URTI) (2 arms), sponsored by Asma Al Shidhani. Primary endpoint: Change in throat pain score. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
pharyngitisupper respiratory tract infection (URTI)
Beyond the preview
Go deeper on ACTRN12618000847213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000847213.